CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition

Malignant pleural mesothelioma is an aggressive cancer, heterogeneous in its presentation and behaviour. Despite an increasing knowledge about molecular markers and their diagnostic and prognostic value, they are not used as much as they might be for treatment allocation. It has been recently report...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinton, Giulia, Wang, Zhuo, Balzano, Cecilia, Missaglia, Sara, Tavian, Daniela, Boldorini, Renzo, Fennell, Dean A., Griffin, Martin, Moro, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281343/
https://www.ncbi.nlm.nih.gov/pubmed/34277422
http://dx.doi.org/10.3389/fonc.2021.678447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281343/
https://www.ncbi.nlm.nih.gov/pubmed/34277422
http://dx.doi.org/10.3389/fonc.2021.678447

Ejemplares similares